Emerging antibacterial biomaterial strategies for the prevention of peri-implant inflammatory diseases

International Journal of Oral and Maxillofacial Implants

Volumn 26, Issue 3, 2011, Pages 553-560

  Bumgardner, Joel D ^a   Adatrow, Pradeep ^a   Haggard, Warren O ^a   Norowski, P Andrew ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Antimicrobial; Biomaterials; Dental implants; Peri implantitis; Peri mucositis; Surfaces

Indexed keywords

ANTIINFECTIVE AGENT; BIOMATERIAL; DRUG CARRIER;

BACTERIAL INFECTION; CHEMISTRY; HUMAN; INFECTION; MICROBIOLOGY; PERIIMPLANTITIS; REVIEW; TOOTH IMPLANTATION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOCOMPATIBLE MATERIALS; COATED MATERIALS, BIOCOMPATIBLE; DENTAL IMPLANTS; DRUG CARRIERS; HUMANS; PERI-IMPLANTITIS; PROSTHESIS-RELATED INFECTIONS;

EID: 84863939356     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Aglietta M, Siciliano VI, Zwahlen M, et al. A systematic review of the survival and complication rates of implant supported fixed dental prostheses with cantilever extensions after an observation period of at least 5 years. Clin Oral Implants Res 2009; 20: 441-451.
2. Lambert FE, Weber HP, Susarla SM, Belser UC, Gallucci GO. Descriptive analysis of implant and prosthodontic survival rates with fixed implant-supported rehabilitations in the edentulous maxilla. J Periodontol 2009; 80: 1220-1230.
3. Jemt T, Johansson J. Implant treatment in the edentulous maxillae: A 15-year follow-up study on 76 consecutive patients provided with fixed prostheses. Clin Implant Dent Relat Res 2006; 8: 61-69.
4. Karoussis IK, Bragger U, Salvi GE, Burgin W, Lang NP. Effect of implant design on survival and success rates of titanium oral implants: A 10-year prospective cohort study of the ITI Dental Implant System. Clin Oral Implants Res 2004; 15: 8-17.
5. Bragger U, Karoussis I, Persson R, Pjetursson B, Salvi G, Lang N. Technical and biological complications/failures with single crowns and fixed partial dentures on implants: A 10-year prospective cohort study. Clin Oral Implants Res 2005; 16: 326-334.
6. Klinge B, Hultin M, Berglundh T. Peri-implantitis. Dent Clin North Am 2005; 49: 661-676.
7. Zitzmann NU, Berglundh T. Definition and prevalence of peri-implant diseases. J Clin Periodontol 2008; 35: 286-291.
8. Mombelli A. Etiology, diagnosis, and treatment considerations in peri-implantitis. Curr Opin Periodontol 1997; 4: 127-136.
9. Romeo E, Ghisolfi M, Carmagnola D. Peri-implant diseases. A systematic review of the literature. Minerva Stomatol 2004; 53: 215-230.
10. Heitz-Mayfield LJ. Peri-implant diseases: Diagnosis and risk indicators. J Clin Periodontol 2008; 35: 292-304.
11. Pye AD, Lockhart DE, Dawson MP, Murray CA, Smith AJ. A review of dental implants and infection. J Hosp Infect 2009; 72: 104-110.
12. Lindhe J, Meyle J. Peri-implant diseases: Consensus report of the sixth European workshop on periodontology. J Clin Periodontol 2008; 35: 282-285.
13. Quirynen M, De Soete M, van Steenberghe D. Infectious risks for oral implants: A review of the literature. Clin Oral Implants Res 2002; 13: 1-19.
14. Heydenrijk K, Meijer HJ, van der Reijden WA, Raghoebar GM, Vissink A, Stegenga B. Microbiota around root-form endosseous implants: A review of the literature. Int J Oral Maxillofac Implants 2002; 17: 829-838.
15. Berglundh T, Persson L, Klinge B. A systematic review of the incidence of biological and technical complications in implant dentistry reported in prospective longitudinal studies of at least 5 years. J Clin Periodontol 2002; 29: 197-212.
16. Bragger U, Aeschlimann S, Burgin W, Hammerle CH, Lang NP. Biological and technical complications and failures with fixed partial dentures (FPD) on implants and teeth after four to five years of function. Clin Oral Implants Res 2001; 12: 26-34.
17. Jung RE, Pjetursson BE, Glauser R, Zembic A, Zwahlen M, Lang NP. A systematic review of the 5-year survival and complication rates of implant-supported single crowns. Clin Oral Implants Res 2008; 19: 119-130.
18. Roos-Jansaker AM, Lindahl C, Renvert H, Renvert S. Nine- to fourteen-year follow-up of implant treatment. Part II: Presence of peri-implant lesions. J Clin Periodontol 2006; 33: 290-295.
19. Legeay G, Poncin-Epaillard F, Arciola CR. New surfaces with hydrophilic/hydrophobic characteristics in relation to (no) bioadhesion. Int J Artif Organs 2006; 29: 453-461.
20. Verran J, Whitehead K. Factors affecting microbial adhesion to stainless steel and other materials used in medical devices. Int J Artif Organs 2005; 28: 1138-1145.
21. Harris LG, Mead L, Muller-Oberlander E, Richards RG. Bacteria and cell cytocompatibility studies on coated medical grade titanium surfaces. J Biomed Mater Res A 2006; 78: 50-58.
22. Maddikeri RR, Tosatti S, Schuler M, et al. Reduced medical infection- related bacterial strains adhesion on bioactive RGD modified titanium surfaces: A first step toward cell-selective surfaces. J Biomed Mater Res A 2008; 84: 425-435.
23. Schuler M, Owen GR, Hamilton DW, et al. Biomimetic modification of titanium dental implant model surfaces using the RGDSP-peptide sequence: A cell morphology study. Biomaterials 2006; 27: 4003-4015.
24. Harris LG, Tosatti S, Wieland M, Textor M, Richards RG. Staphylococcus aureus adhesion to titanium oxide surfaces coated with non-functionalized and peptide-functionalized poly(L-lysine)-grafted-poly(ethylene glycol) copolymers. Biomaterials 2004; 25: 4135-4148.
25. VandeVondele S, Voros J, Hubbell JA. RGD-grafted poly-L-lysine-graft-(polyethylene glycol) copolymers block nonspecific protein adsorption while promoting cell adhesion. Biotechnol Bioeng 2003; 82: 784-790.
26. Tosatti S, De Paul SM, Askendal A, et al. Peptide functionalized poly(L-lysine)-g-poly(ethylene glycol) on titanium:Resistance to protein adsorption in full heparinized human blood plasma. Biomaterials 2003; 24: 4949-4958.
27. Mills A, LeHunte S. An overview of semiconductor photocatalysis. J Photoch Photobiol A 1997; 108: 1-35.
28. Del Curto B, Brunella MF, Giordano C, et al. Decreased bacterial adhesion to surface-treated titanium. Int J Artif Organs 2005; 28: 718-730.
29. Rehman S, Ullah R, Butt AM, Gohar ND. Strategies of making TiO2 and ZnO visible light active. J Hazard Mater 2009; 170: 560-569.
30. Blake DM, Maness PC, Huang Z, Wolfrum EJ, Huang J, Jacoby WA. Application of the photocatalytic chemistry of titanium dioxide to disinfection and the killing of cancer cells. Separ Purif Method 1999; 28: 1-50.
31. Pacheco JE, Prairie MR, Yellowhorse L. Photocatalytic destruction of chlorinated solvents in water with solar-energy. J Sol Energ-T Asme 1993; 115: 123-129.
32. Maness PC, Smolinski S, Blake DM, Huang Z, Wolfrum EJ, Jacoby WA. Bactericidal activity of photocatalytic TiO(2) reaction:Toward an understanding of its killing mechanism. Appl Environ Microbiol 1999; 65: 4094-4098.
33. Sollazzo V, Pezzetti F, Scarano A, et al. Anatase coating improves implant osseointegration in vivo. J Craniofac Surg 2007; 18: 806-810.
34. Petrini P, Arciola CR, Pezzali I, et al. Antibacterial activity of zinc modified titanium oxide surface. Int J Artif Organs 2006; 29: 434-442.
35. Sumita T, Yamaki T, Yamamoto S, Miyashita A. Photo-induced surface charge separation of highly oriented TiO2 anatase and rutile thin films. Appl Surf Sci 2002; 200: 21-26.
36. Suketa N, Sawase T, Kitaura H, et al. An antibacterial surface on dental implants, based on the photocatalytic bactericidal effect. Clin Implant Dent Relat Res 2005; 7: 105-111.
37. Oka Y, Kim WC, Yoshida T, et al. Efficacy of titanium dioxide photocatalyst for inhibition of bacterial colonization on percutaneous implants. J Biomed Mater Res B Appl Biomater 2008;86B:530-540.
38. Aita H, Hori N, Takeuchi M, et al. The effect of ultraviolet functionalization of titanium on integration with bone. Biomaterials 2009; 30: 1015-1025.
39. Wong MS, Chu WC, Sun DS, et al. Visible-light-induced bactericidal activity of a nitrogen-doped titanium photocatalyst against human pathogens. Appl Environ Microbiol 2006; 72: 6111-6116.
40. Yoshinari M, Oda Y, Kato T, Okuda K. Influence of surface modifications to titanium on antibacterial activity in vitro. Biomaterials 2001; 22: 2043-2048.
41. Yoshinari M, Oda Y, Kato T, Okuda K, Hirayama A. Influence of surface modifications to titanium on oral bacterial adhesion in vitro. J Biomed Mater Res 2000; 52: 388-394.
42. Ewald A, Gluckermann SK, Thull R, Gbureck U. Antimicrobial titanium/silver PVD coatings on titanium. Biomed Eng Online 2006; 5: 22.
43. Das K, Bose S, Bandyopadhyay A, Karandikar B, Gibbins BL. Surface coatings for improvement of bone cell materials and antimicrobial activities of Ti implants. J Biomed Mater Res B Appl Biomater 2008; 87: 455-460.
44. Heidenau F, Mittelmeier W, Detsch R, et al. A novel antibacterial titania coating: Metal ion toxicity and in vitro surface colonization. J Mater Sci 2005; 16: 883-888.
45. Shibata Y, Kawai H, Yamamoto H, Igarashi T, Miyazaki T. Antibacterial titanium plate anodized by being discharged in NaCl solution exhibits cell compatibility. J Dent Res 2004; 83: 115-119.
46. Montanaro L, Campoccia D, Arciola CR. Nanostructured materials for inhibition of bacterial adhesion in orthopedic implants: A minireview. Int J Artif Organs 2008; 31: 771-776.
47. Pecora GE, Ceccarelli R, Bonelli M, Alexander H, Ricci JL. Clinical evaluation of laser microtexturing for soft tissue and bone attachment to dental implants. Implant Dent 2009; 18: 57-66.
48. Colon G, Ward BC, Webster TJ. Increased osteoblast and decreased Staphylococcus epidermidis functions on nanophase ZnO and TiO2. J Biomed Mater Res A 2006; 78: 595-604.
49. Popat KC, Eltgroth M, Latempa TJ, Grimes CA, Desai TA. Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 2007; 28: 4880-4888.
50. Schmidmaier G, Lucke M, Wildemann B, Haas NP, Raschke M. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: A review. Injury 2006; 37: S105-S112.
51. Kalicke T, Schierholz J, Schlegel U, et al. Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: An in vitro and in vivo study. J Orthop Res 2006; 24: 1622-1640.
52. Radin S, Ducheyne P. Controlled release of vancomycin from thin sol-gel films on titanium alloy fracture plate material. Biomaterials 2007; 28: 1721-1729.
53. Radin S, El-Bassyouni G, Vresilovic EJ, Schepers E, Ducheyne P. In vivo tissue response to resorbable silica xerogels as controlled- release materials. Biomaterials 2005; 26: 1043-1052.
54. Chen W, Liu Y, Courtney HS, et al. In vitro antibacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating. Biomaterials 2006; 27: 5512-5517.
55. Chen W, Oh S, Ong AP, et al. Antibacterial and osteogenic properties of silver-containing hydroxyapatite coatings produced using a sol gel process. J Biomed Mater Res A 2007; 82: 899-906.
56. Stigter M, Bezemer J, de Groot K, Layrolle P. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release 2004; 99: 127-137.
57. Darouiche RO, Mansouri MD, Zakarevicz D, Alsharif A, Landon GC. In vivo efficacy of antimicrobial-coated devices. J Bone Joint Surg Am 2007; 89: 792-797.
58. Norowski PA, Courtney HS, Babu J, Haggard WO, Bumgardner JD. Chitosan coatings deliver antimicrobials from titanium implants: A preliminary study. Implant Dent 2011; 20: 56-67.
59. Greene AH, Bumgardner JD, Yang Y, Moseley J, Haggard WO. Chitosan-coated stainless steel screws for fixation in contaminated fractures. Clin Orthop Relat Res 2008; 466: 1699-1704.
60. Norowski PA Jr, Bumgardner JD. Biomaterial and antibiotic strategies for peri-implantitis: A review. J Biomed Mater Res B Appl Biomater 2009; 88: 530-543.
61. Di Martino A, Sittinger M, Risbud MV. Chitosan: A versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 2005; 26: 5983-5990.
62. Bumgardner JD, Chesnutt BM, Yuan Y, et al. The integration of chitosan-coated titanium in bone: An in vivo study in rabbits. Implant Dent 2007; 16: 66-79.
63. Suzuki Y, Tanihara M, Nishimura Y, Suzuki K, Kakimaru Y, Shimizu Y. A new drug delivery system with controlled release of antibiotic only in the presence of infection. J Biomed Mater Res 1998; 42: 112-116.
64. Woo GL, Mittelman MW, Santerre JP. Synthesis and characterization of a novel biodegradable antimicrobial polymer. Biomaterials 2000; 21: 1235-1246.